Image

Amikar Sehdev, MD, MPH, FACP

Medical Oncologist

Gastrointestinal Malignancies

Skin & Sarcoma

"He supported our entire family during a difficult time, and we feel so appreciative for his knowledge, calm demeanor and caring nature."

Amikar Sehdev, MD, MPH, FACP is a board-certified medical oncologist and hematologist who has been practicing medicine for over 10 years. He received his medical degree from the Government Medical College and Hospital in Chandigarh, India where he was a National Merit Scholarship recipient. He completed his residency at John H. Stroger, Jr. Hospital of Cook County in Chicago, and his fellowship at the renowned University of Chicago. Dr. Sehdev also has a master’s degree in public health with specialization in health promotion.

Before joining Ironwood Cancer Research Centers, Dr. Sehdev has worked at Indiana University. During this time, he participated in many clinical research trials as the principal investigator and served in leadership roles. He has authored many publications in high-impact scientific journals and has presented his findings at ASCO meetings. He has served as a nominated panel member for writing the American Society of Clinical Oncology (ASCO) clinical practice guidelines for malignant melanoma. He is a Fellow of the American College of Physicians and a member of the ASCO, the American Society of Hematology, and the American Medical Association.

Dr. Sehdev specializes in gastrointestinal and skin malignancies as well as sarcomas and hematologic disorders. He is at present an investigator in research trials. His practice philosophy is to develop a high-quality individualized care plan by compassionately listening to his patients and integrating a team-based approach for the best outcomes.

Dr. Sehdev is actively involved in the education of medical students and residents Midwestern University and serves as extended faculty. Aside from medicine, he enjoys running, reading, photography, playing chess and spending time with his family.

Present Title & Subspecialties

Title

Medical Oncology & Hematology

Subspecialties

Gastrointestinal MalignanciesSkin & Sarcoma

Education & Training

Medical School

Government Medical College, Chandigarh India

Fellowships

University of Chicago, Illinois ,Medical Oncology & Hematology
Cancers Treated
Certifications & Professional Memberships

  • Board Certified in Medical Oncology & Hematology
  • Board Certified in Internal Medicine
  • American Society of Clinical Oncology
  • American Society of Hematology
  • American Medical Association (AMA)
  • American College of Physicians (ACP)

Publications

Peer-reviewed publications in the primary literature, exclusive of abstracts:

Systemic Therapy for Melanoma: ASCO Guideline Update | Journal of Clinical Oncology (ascopubs.org)

Fichera A, Sehdev A, Bissonnette M, et al. EGFR Signaling is Required for Microadenoma Formation in the Mouse Azoxymethane Model of Colonic Carcinogenesis. Cancer Research. 2007 Jan; 67(2): 827-835

 

Dougherty U, Sehdev A, Bissonnette M, et al. EGFR Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model. Clinical Cancer Research. 2008 Apr; 14(8): 2253-62

 

Dougherty U, Sehdev A, Bissonnette M, et al. EGFR is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of TGF-α and PTGS2. Clinical Cancer Research. 2009 Nov; 15(22): 6780-6789

 

Sehdev A and Dhoble A. Pulmonary Artery Dissection: A Very Unusual Cause of Chest Pain. Journal of Hospital Medicine. 2010 May; 5(5): 313-316

 

Lash A, Sehdev A and Plonczynski D. Trends in Hypothesis Testing and Related Variables in Nursing Research: a Retrospective Exploratory Study. 2011; 18 (3): 38-44

 

Sehdev A, Wanner N, Pendleton RC. Statins for the Prevention of Venous Thromboembolism? A Narrative Review. Hosp Pract (Minneap). 2012 Aug;40(3):13-8

 

Sehdev A, Zhao Y, Singh AK and Sharma N. Primary Small Cell Carcinoma of the Tonsil: A Case Report and Review of the Literature. Case Rep Oncol. 2012 Sep;5(3):537-41

 

Sehdev A and Catenacci DVT: Gastroesophageal Cancer: Focus on Epidemiology, Classification and Staging. Discovery Medicine 2013, 16(87):103111

 

Sehdev A and Catenacci DVT: Perioperative Therapy for Locally Advanced Gastroesophageal Cancer: Current Controversies and Consensus of Care. Journal of Hematology & Oncology 2013, Sep 5;6(1):66

 

Sehdev A and Polite BP: Modern Chemoradiation and Chemotherapy Protocols for Locally Advanced Rectal Cancer: The Current and Future Standards of Care. Seminars in Colon and Rectal Surgery 2013, 24(3):132-141

 

Sehdev A, Shih T, Vekhter B, Lyttle C, Huo D and Polite BP: The Role of Statins for Primary Prevention in Non-elderly Colorectal Cancer Patients. Anticancer Research 2014, 34(9): 1-8

 

Sehdev A, Shih T, Vekhter B, Bissonnette MB, Olopade OI and Polite BP. Metformin for Primary Colorectal Cancer Prevention in Diabetic Patients: A Case-Control Study in a US Population. Cancer 2014, Nov 25

 

Valsangkar N, Sehdev A, Misra S, Zimmers TA, O’Neil BH, and Koniaris LG. Current management of gastrointestinal stromal tumors: Surgery, current biomarkers, mutations, and therapy. Surgery, June 2015

 

Sehdev A and O’Neil BH. The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer. Current Treatment Options in Oncology. September 2015, 16:43

 

Sehdev A, Cramer H, Ibrahim AA, Younger AE and O’Neil BH. Pathological Complete Response with Anti-PD1 Therapy in a Patient with Microsatellite Instable High, BRAF Mutant Metastatic Colon Cancer: A Case Report and Review of Literature. Discovery Medicine. May 22, 2016

 

Sehdev A, Sherer EA, Hui SL, Wu J and Haggstrom DA. Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities. Cancer, 2017 Jun 15;123(12):2338-2351

 

Dadi N, Stanley M, Shahda S, O’Neil BH and Sehdev A. Impact of Nab–Paclitaxel-based Second- line Chemotherapy in Metastatic Pancreatic Cancer. Anticancer Research October 2017 vol. 37 no. 10 5533-5539

 

Sehdev A, Karrison T, Zha Y, Sharma MR et al. A Pharmacodynamic Study of Sirolimus and Metformin in Patients with Advanced Solid Tumors. Cancer Chemother Pharmacol. 2018 Aug;82(2):309-317

 

Sehdev A, Gbolahan O, Hancock BA, O’Neil BH et al. Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX. Clinical Cancer Research. DOI: 10.1158/1078-0432.CCR-18-1472

 

DeWitt JM, Sandrasegaran K, O’Neil B, House MG, Zyromski NJ, Sehdev A, Perkins SM, Flynn J, McCranor L, Shahda S. Phase I Study of EUS-guided Photodynamic Therapy for Locally Advanced Pancreatic Cancer. Gastrointest Endosc. 2018 Sep 14 [Epub ahead of print]

 

Milgrom DP, Sehdev A, Kays JK, Koniaris LG. Integrating therapies for surgical adult soft tissue sarcoma patients. Translational Gastroenterology and Hepatology 2018, 3:88

 

Gbolahan OB, Tong Y, Sehdev A, O’Neil BH, Shahda S. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study. BMC Cancer. 2019 May; 19 (1): 468

 

Joshi SS, Catenacci DVT, Karrison TG, Peterson JD, Zalupski MM, Sehdev A et al. 5- fluorouracil/leucovorin, nab-paclitaxel, and irinotecan with UGT1A1 genotype-guided dosing (FOLFIRABRAX) in untreated patients with gastrointestinal malignancies. Accepted in Clinical Cancer Research July 24, 2019

 

Patel AS, Snook RJ, Sehdev A. Chronic Inflammatory Demyelinating Polyradiculoneuropathy Secondary to Immune Checkpoint Inhibitors in Melanoma Patients. Discovery Medicine 2019, Aug; 28(152)

 

Book chapters:

Sehdev A and Marsh R. Contribution of Chemotherapy to the Toxicity of Pelvic Irradiation. Book Chapter. Radiation Therapy for Pelvic Malignancy and its Consequences. Editors, Ehrenpreis, Marsh and Small. Publisher, Springer. Publication date, August 2014.

 

Non-peer-reviewed original articles

Sehdev, A. Genetics and Cancer Prevention: Focus on Colorectal Cancer. 

 

Sehdev, A. ASCO MedPage Today Expert Critique. Melanoma Gene-expression Biomarker Predicts Immunotherapy Response. Dated Oct 20, 2018

 

Sehdev, A. ASCO MedPage Today Expert Critique. Improved Immunotherapy Response in Melanoma Patients with Genetic Mutations. Dated Nov 8, 2018

 

Sehdev, A. ASCO MedPage Today Expert Critique. Liquid Biopsy and MSI in Multiple tumors. Dated Sept 9, 2019

 

Sehdev, A. ASCO MedPage Today Expert Critique. Long-Term QOL for Melanoma Patients on Immunotherapy. Dated Oct 31, 2019

 

Sehdev, A. ASCO MedPage Today Expert Critique. BRAF-Mutated Metastatic Melanoma: Recent Research Context. Dated Nov 23, 2019

Honors & Awards

Heroes Foundation SJP Scholar, Heroes Foundation, 2016

Illinois Medical Oncology Society Fellows Research Competition Winner, 2013

Clinical and Translational Science Award, University of Chicago, Chicago, IL, 2012

Kozloff Fellow of the Year 2012

CV
Videos

Videos

Languages

Location

Glendale

5810 W. Beverly Ln

Glendale, AZ 85306

Hours:

Monday- Friday

8am-5pm

Contact
(623) 312-3000
(623) 312-3060
Goodyear

1710 N 159th Ave, Goodyear, AZ 85395

HOURS:

MONDAY- FRIDAY

8AM-5PM

Contact
623-312-3020
623-487-6747
Reviews for Amikar Sehdev, MD, MPH, FACP
  • Sehdev Testimonial
  • Image
  • Image
  • Image
  • Sehdev Testimonial
  • Sehdev, Murty, Vaidya Testimonial
  • Sehdev Testimonial
  • Sehdev Testimonial
  • Sehdev Testimonial
  • Sehdev Testimonial
  • Sehdev Testimonial
  • Image
  • Sehdev Testimonial
  • Sehdev Testimonial
    pixel